{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:20:48Z","timestamp":1767046848767},"reference-count":46,"publisher":"BMJ","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.n1467","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T11:05:13Z","timestamp":1624359913000},"page":"n1467","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Future of covid-19 vaccine pricing: lessons from influenza"],"prefix":"10.1136","author":[{"given":"Reshma","family":"Ramachandran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Dhodapkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason L","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"2021062208000558000_373.jun22_1.n1467.1","doi-asserted-by":"crossref","unstructured":"Cross S Rho Y Reddy H . Who funded the research behind the Oxford-AstraZeneca COVID-19 vaccine? Approximating the funding to the University of Oxford for the research and development of the ChAdOx vaccine technology. medRxiv 2021 Apr 10. [Preprint.] https:\/\/www.medrxiv.org\/content\/10.1101\/2021.04.08.21255103v1","DOI":"10.1101\/2021.04.08.21255103"},{"key":"2021062208000558000_373.jun22_1.n1467.2","unstructured":"BioNTech. BioNTech to Receive up to \u20ac375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162. 2020. Available from: https:\/\/investors.biontech.de\/news-releases\/news-release-details\/biontech-receive-eu375m-funding-german-federal-ministry\/"},{"key":"2021062208000558000_373.jun22_1.n1467.3","unstructured":"US Government Accountability Office. Covid-19: federal efforts accelerate vaccine and therapeutic development, but more transparency needed on emergency use authorizations. 2020. https:\/\/www.gao.gov\/assets\/720\/710691.pdf"},{"key":"2021062208000558000_373.jun22_1.n1467.4","unstructured":"Schakowsky J. Question and answer portion of House oversight and investigations committee hearing: \u201cPathways to a vaccine: efforts to develop a safe, effective, and accessible covid-19 vaccine\u201d 21 Jul 2020. https:\/\/www.youtube.com\/watch?v=wVbqNZCtLJY&feature=youtu.be"},{"key":"2021062208000558000_373.jun22_1.n1467.5","unstructured":"Cormier Z. The second-generation covid vaccines are coming. Scientific American 2021 Jan 20. https:\/\/www.scientificamerican.com\/article\/the-second-generation-covid-vaccines-are-coming\/"},{"key":"2021062208000558000_373.jun22_1.n1467.6","unstructured":"Tirrell M. Moderna looks to test Covid-19 booster shots a year after initial vaccination. CNBC 2021 Jan 14. https:\/\/www.cnbc.com\/2021\/01\/14\/moderna-looks-to-test-covid-19-booster-shots-a-year-after-initial-vaccination.html"},{"key":"2021062208000558000_373.jun22_1.n1467.7","unstructured":"Lovelace B Jr. Pfizer CEO says third Covid vaccine dose likely needed within 12 months. CNBC 2021 Apr 15. https:\/\/www.cnbc.com\/2021\/04\/15\/pfizer-ceo-says-third-covid-vaccine-dose-likely-needed-within-12-months.html"},{"key":"2021062208000558000_373.jun22_1.n1467.8","unstructured":"Moderna. Statement by Moderna on intellectual property matters during the covid-19 pandemic. 2020. https:\/\/investors.modernatx.com\/news-releases\/news-release-details\/statement-moderna-intellectual-property-matters-during-covid-19\/"},{"key":"2021062208000558000_373.jun22_1.n1467.9","unstructured":"Mancini DP. AstraZeneca vaccine document shows limit of no-profit pledge. Financial Times 2020 Oct 7. https:\/\/www.ft.com\/content\/c474f9e1-8807-4e57-9c79-6f4af145b686"},{"key":"2021062208000558000_373.jun22_1.n1467.10","unstructured":"Fang L. Drugmakers promise investors they\u2019ll soon hike covid-19 vaccine prices. The Intercept 2021 Mar 18. https:\/\/theintercept.com\/2021\/03\/18\/covid-vaccine-price-pfizer-moderna\/"},{"key":"2021062208000558000_373.jun22_1.n1467.11","unstructured":"Wood P. Pfizer hikes cost of Covid vaccine for EU by 60 per cent. CityAM 2021 Apr 13. https:\/\/www.cityam.com\/pfizer-hikes-cost-of-covid-vaccine-for-eu-by-60-per-cent\/"},{"key":"2021062208000558000_373.jun22_1.n1467.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4750"},{"key":"2021062208000558000_373.jun22_1.n1467.13","unstructured":"Owermohle S. US government buys another 100 million doses of Moderna vaccine. Politico 2020 Dec 11. https:\/\/www.politico.com\/news\/2020\/12\/11\/government-buys-moderna-vaccine-444626"},{"key":"2021062208000558000_373.jun22_1.n1467.14","unstructured":"Pfizer. Pfizer and BioNTech to supply the US. with 100 million additional doses of covid-19 vaccine. Press release, 23 Dec 2020. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-supply-us-100-million-additional-doses"},{"key":"2021062208000558000_373.jun22_1.n1467.15","unstructured":"Stevis-Gridneff M, Sanger-Katz M, Weiland N. A European official reveals a secret: the US is paying more for coronavirus vaccines. New York Times 2020 Dec 18. https:\/\/www.nytimes.com\/2020\/12\/18\/upshot\/coronavirus-vaccines-prices-europe-united-states.html"},{"key":"2021062208000558000_373.jun22_1.n1467.16","unstructured":"World Health Organization. Draft landscape and tracker of COVID-19 candidate vaccines. 2021. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines"},{"key":"2021062208000558000_373.jun22_1.n1467.17","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6522"},{"key":"2021062208000558000_373.jun22_1.n1467.18","unstructured":"National Institutes of Health. NIH clinical trial evaluating Moderna covid-19 variant vaccine begins. Press release, 1 Apr 2021; https:\/\/www.nih.gov\/news-events\/news-releases\/nih-clinical-trial-evaluating-modera-covid-19-variant-vaccine-begins"},{"key":"2021062208000558000_373.jun22_1.n1467.19","unstructured":"Pfizer. Pfizer and BioNTech initiate a study as part of broad development plan to evaluate covid-19 booster and new vaccine variants. Press release, 25 Feb 2021. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-initiate-study-part-broad-development"},{"key":"2021062208000558000_373.jun22_1.n1467.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.030"},{"key":"2021062208000558000_373.jun22_1.n1467.21","unstructured":"National Institute of Allergy and Infectious Diseases. Influenza vaccines. https:\/\/www.niaid.nih.gov\/diseases-conditions\/influenza-vaccines"},{"key":"2021062208000558000_373.jun22_1.n1467.22","unstructured":"FDA. FDA\u2019s Critical role in ensuring supply of influenza vaccine. 2020. https:\/\/www.fda.gov\/consumers\/consumer-updates\/fdas-critical-role-ensuring-supply-influenza-vaccine"},{"key":"2021062208000558000_373.jun22_1.n1467.23","unstructured":"Roos R. None of Chiron\u2019s flu vaccine is safe, FDA says. CIDRAP 2004 Oct 15. https:\/\/www.cidrap.umn.edu\/news-perspective\/2004\/10\/none-chirons-flu-vaccine-safe-fda-says"},{"key":"2021062208000558000_373.jun22_1.n1467.24","first-page":"989","article-title":"Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010-11","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021062208000558000_373.jun22_1.n1467.25","unstructured":"Schnirring L. Pharmacy chains poised for universal flu vaccination push. CIDRAP News 2010 Aug 18. https:\/\/www.cidrap.umn.edu\/news-perspective\/2010\/08\/pharmacy-chains-poised-universal-flu-vaccination-push"},{"key":"2021062208000558000_373.jun22_1.n1467.26","unstructured":"Sun LH. CDC and drugmakers boost flu vaccine doses amid fears of an unprecedented respiratory illness season. Washington Post 2020 Jun 24. https:\/\/www.washingtonpost.com\/health\/2020\/06\/24\/cdc-drugmakers-boost-flu-vaccine-doses-amid-fears-an-unprecedented-respiratory-illness-season\/"},{"key":"2021062208000558000_373.jun22_1.n1467.27","unstructured":"Centers for Disease Control and Prevention. CDC vaccine price list. 2021 https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/index.html"},{"key":"2021062208000558000_373.jun22_1.n1467.28","unstructured":"Elder M. The global influenza market. BCC Research, 2018. https:\/\/www.bccresearch.com\/market-research\/pharmaceuticals\/the-global-influenza-market.html"},{"key":"2021062208000558000_373.jun22_1.n1467.29","unstructured":"Collis H. UK buys extra 60 million doses of BioNTech\/Pfizer covid-19 vaccine. Politico 2021 Apr 28. https:\/\/www.politico.eu\/article\/uk-buys-extra-60-million-doses-of-biontech-pfizer-covid-19-vaccine\/"},{"key":"2021062208000558000_373.jun22_1.n1467.30","unstructured":"King R. HHS officials tells Congress COVID-19 booster vaccine shot could be needed. FierceHealthcare 2021 May 11. https:\/\/www.fiercehealthcare.com\/payer\/hhs-officials-tells-congress-covid-19-booster-vaccine-shot-could-be-needed"},{"key":"2021062208000558000_373.jun22_1.n1467.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5375"},{"key":"2021062208000558000_373.jun22_1.n1467.32","unstructured":"Robbins R, Goodman PS. Pfizer reaps hundreds of millions in profits from covid vaccine. New York Times 2021 May 4. https:\/\/www.nytimes.com\/2021\/05\/04\/business\/pfizer-covid-vaccine-profits.html"},{"key":"2021062208000558000_373.jun22_1.n1467.33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.35064"},{"key":"2021062208000558000_373.jun22_1.n1467.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.11.013"},{"key":"2021062208000558000_373.jun22_1.n1467.35","unstructured":"Winning A. South Africa to pay $5.25 a dose for AstraZeneca vaccine from India\u2019s SII. Reuters 2021 Jan 21. https:\/\/www.reuters.com\/article\/uk-health-coronavirus-safrica-vaccines-idUSKBN29Q1O2"},{"key":"2021062208000558000_373.jun22_1.n1467.36","unstructured":"Raghavan P, Sasi A. Serum Institute\u2019s Rs 600\/dose for Covishield in private hospitals is its highest rate the world over. Indian Express 2021 Apr 25. https:\/\/indianexpress.com\/article\/india\/serum-institute-covishield-price-india-world-7286635\/"},{"key":"2021062208000558000_373.jun22_1.n1467.37","unstructured":"Nakkazi E. Uganda defends price paid for AstraZeneca Covid19 vaccine; new study suggests vaccine could cut transmission by two-thirds. Health Policy Watch, 2021. https:\/\/healthpolicy-watch.news\/uganda-defends-astrazeneca-price-says-its-not-higher-than-other-countries"},{"key":"2021062208000558000_373.jun22_1.n1467.38","unstructured":"World Trade Organization. India, South Africa. Waiver from certain provisions of the trips agreement for the prevention, containment and treatment of covid-19. 2020. https:\/\/docs.wto.org\/dol2fe\/Pages\/SS\/directdoc.aspx?filename=q:\/IP\/C\/W669.pdf&Open=True"},{"key":"2021062208000558000_373.jun22_1.n1467.39","unstructured":"Office of the United States Trade Representative. Statement from Ambassador Katherine Tai on the covid-19 trips waiver. Press release, May 2021. https:\/\/ustr.gov\/about-us\/policy-offices\/press-office\/press-releases\/2021\/may\/statement-ambassador-katherine-tai-covid-19-trips-waiver"},{"key":"2021062208000558000_373.jun22_1.n1467.40","unstructured":"World Trade Organization. Members approach text-based discussions for an urgent IP response to COVID-19. WTO News 2021. https:\/\/www.wto.org\/english\/news_e\/news21_e\/trip_09jun21_e.htm"},{"key":"2021062208000558000_373.jun22_1.n1467.41","unstructured":"The Peoples Vaccine. FAQ. https:\/\/peoplesvaccine.org\/faq\/"},{"key":"2021062208000558000_373.jun22_1.n1467.42","unstructured":"World Health Organization. Establishment of a COVID-19 mRNA vaccine technology transfer hub to scale up global manufacturing. 2021. https:\/\/www.who.int\/news-room\/articles-detail\/establishment-of-a-covid-19-mrna-vaccine-technology-transfer-hub-to-scale-up-global-manufacturing"},{"key":"2021062208000558000_373.jun22_1.n1467.43","unstructured":"Lerner S, Fang L. Factory owners around the world stand ready to manufacture covid-19 vaccines. Intercept 2021 Apr 29. https:\/\/theintercept.com\/2021\/04\/29\/covid-vaccine-factory-production-ip\/"},{"key":"2021062208000558000_373.jun22_1.n1467.44","unstructured":"Herman B. Moderna skirts disclosures of coronavirus vaccine costs. Axios 2020 Aug 5. https:\/\/www.axios.com\/moderna-barda-coronavirus-funding-disclosure-2775a517-a775-485a-a509-b6906c8535a9.html"},{"key":"2021062208000558000_373.jun22_1.n1467.45","unstructured":"Ardizzone K. Novavax and Inovio covid-19 vaccine contracts limit prices companies can charge for their products. Knowledge Ecology International 2021 Jan 28https:\/\/www.keionline.org\/35185"},{"key":"2021062208000558000_373.jun22_1.n1467.46","unstructured":"Ardizzone K. $1.8 billion Sanofi vaccine contract contains international reference pricing clause, preserves Standard IP and data rights. Knowledge Ecology International 2020 Dec 2. https:\/\/www.keionline.org\/34776"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.n1467","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.n1467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T15:47:20Z","timestamp":1624376840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.n1467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":46,"alternative-id":["10.1136\/bmj.n1467"],"URL":"https:\/\/doi.org\/10.1136\/bmj.n1467","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]}}}